Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
4191 - 4200 of 8816 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Essential tremor and cognitive decline
    2021
    Summary Details
    RESTRICTED
    Title: Essential tremor and cognitive decline
    Author(s): Holly A. Shill, Shyamal H. Mehta, Charles H. Adler
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 125
    End Page: 125
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.012
    Citation Count: 3
  • Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study
    2021
    Summary Details
    OPEN
    Title: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study
    Author(s): Christos Koros, Athina‐Maria Simitsi, Nikolaos Papagiannakis, Anastasia Bougea, Andreas Prentakis, Dimitra Papadimitriou, Ioanna Pachi, Roubina Antonelou, Efthalia Angelopoulou, Ion Beratis, Maria Bozi, Sokratis G. Papageorgiou, Xenia Geronicola Trapali, María Stamelou, Leonidas Stefanis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 84
    Issue #:
    Start Page: 1
    End Page: 4
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020
    Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.12.020
    Citation Count: 17
  • Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
    2021
    Summary Details
    OPEN
    Title: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
    Author(s): Regina Katzenschlager, Werner Poewe, Olivier Rascol, Claudia Trenkwalder, Günther Deuschl, К. Ray Chaudhuri, Tove Henriksen, Teus van Laar, Donna Lockhart, Harry Staines, Andrew J. Lees
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 79
    End Page: 85
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024
    Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdf
    Citation Count: 66
  • Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”
    2021
    Summary Details
    RESTRICTED
    Title: Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”
    Author(s): Christopher Kobylecki, Monty Silverdale
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 128
    End Page: 129
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.011
    Citation Count: 0
  • Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression
    2021
    Summary Details
    RESTRICTED
    Title: Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression
    Author(s): Ryul Kim, Sangmin Park, Dallah Yoo, Jin‐Sun Jun, Beomseok Jeon
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 66
    End Page: 70
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.004
    Citation Count: 11
  • Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing study
    2021
    Summary Details
    RESTRICTED
    Title: Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing study
    Author(s): Marina Picillo, Monia Ginevrino, Giovanna Dati, Sara Scannapieco, Annamaria Vallelunga, Pietro Siano, Giampiero Volpe, Roberto Ceravolo, Valentina Nicoletti, Calogero Edoardo Cicero, Alessandra Nicoletti, Mario Zappia, Silvia Peverelli, Vincenzo Silani, Maria Teresa Pellecchia, Enza Maria Valente, Paolo Barone
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 84
    Issue #:
    Start Page: 82
    End Page: 90
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.024
    Citation Count: 2
  • Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's disease
    2021
    Summary Details
    OPEN
    Title: Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's disease
    Author(s): Sumeet Kumar, Masoom M. Abbas, Shyla T. Govindappa, Uday B. Muthane, Madhuri Behari, Sanjay Pandey, Ramesh C. Juyal, B.K. Thelma
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 84
    Issue #:
    Start Page: 61
    End Page: 67
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.001
    Citation Count: 9
  • White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease
    2021
    Summary Details
    OPEN
    Title: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease
    Author(s): Mahsa Dadar, Janis M. Miyasaki, Simon Duchesne, Richard Camicioli
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 85
    Issue #:
    Start Page: 95
    End Page: 101
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031
    Citation Count: 14
  • Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
    2021
    Summary Details
    OPEN
    Title: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
    Author(s): Lucas Udovin, Matilde Otero‐Losada, Sofía Bordet, Guenson Chevalier, Cecilia Quarracino, Francisco Capani, Santiago Pérez-Lloret
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 86
    Issue #:
    Start Page: 34
    End Page: 37
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007
    Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625
    Citation Count: 12
  • Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores
    2021
    Summary Details
    OPEN
    Title: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores
    Author(s): Johann Faouzi, Baptiste Couvy‐Duchesne, Samir Bekadar, Olivier Colliot, Jean‐Christophe Corvol
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 86
    Issue #:
    Start Page: 74
    End Page: 77
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003
    Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.